Stem cell injection aims to repair kidneys in diabetes patients

NCT ID NCT07396155

Recruiting now Disease control Sponsor: PT. Prodia Stem Cell Indonesia Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a one-time injection of stem cells from donated umbilical cords into the kidneys of 10 adults with diabetic kidney disease. The goal is to see if the treatment is safe and whether it can improve kidney function and reduce inflammation over 12 months. All participants receive the stem cells, and their results are compared to their own starting measurements.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: umbilical cord stem cells
What this could lead to: If this works, it could point toward a new way to slow or improve kidney damage in people with diabetes.
What could go wrong: This is a very small, early-phase trial with only 10 people and no comparison group. It's too soon to know if the stem cells actually help, and there may be unknown side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC NEPHROPATHY TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic kidney disease kidney disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC NEPHROPATHY TYPE 2

Contacts and locations

Locations

Dr. Sardjito General Hospital
RECRUITING

Yogyakarta, 55284, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.